×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Kirchgraber Paul R

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
LHLABORATORY CORP OF AMERICA HOLDINGSKirchgraber Paul RCEO, Covance Drug DevelopmentMay 19, 2023Option Exercise$182.514,300784,79317,246May 23, 2023, 08:06 AM
LHLABORATORY CORP OF AMERICA HOLDINGSKirchgraber Paul RCEO, Covance Drug DevelopmentMay 19, 2023Sale$216.914,300932,70712,946May 23, 2023, 08:06 AM
LHLABORATORY CORP OF AMERICA HOLDINGSKirchgraber Paul RCEO, Covance Drug DevelopmentMar 30, 2023Option Exercise$224.702,886648,48412,946Apr 03, 2023, 10:13 AM
LHLABORATORY CORP OF AMERICA HOLDINGSKirchgraber Paul RCEO, Covance Drug DevelopmentFeb 21, 2023Option Exercise$182.513,000547,53017,069Feb 23, 2023, 09:54 AM
LHLABORATORY CORP OF AMERICA HOLDINGSKirchgraber Paul RCEO, Covance Drug DevelopmentFeb 21, 2023Sale$250.588,0002,004,6759,069Feb 23, 2023, 09:54 AM
LHLABORATORY CORP OF AMERICA HOLDINGSKirchgraber Paul RCEO, Covance Drug DevelopmentFeb 13, 2023Option Exercise$248.1314235,23414,069Feb 14, 2023, 02:57 PM
LHLABORATORY CORP OF AMERICA HOLDINGSKirchgraber Paul RCEO, Covance Drug DevelopmentFeb 06, 2023Option Exercise$244.5016440,09813,728Feb 07, 2023, 02:51 PM
LHLABORATORY CORP OF AMERICA HOLDINGSKirchgraber Paul RCEO, Covance Drug DevelopmentFeb 02, 2023Option Exercise$254.9914135,95413,332Feb 06, 2023, 03:45 PM
LHLABORATORY CORP OF AMERICA HOLDINGSKirchgraber Paul RCEO, Covance Drug DevelopmentNov 01, 2022Option Exercise$222.56892198,52413,030Nov 03, 2022, 05:00 PM
LHLABORATORY CORP OF AMERICA HOLDINGSKirchgraber Paul RCEO, Covance Drug DevelopmentMar 28, 2022Option Exercise$276.421,648455,54011,915Mar 29, 2022, 12:04 PM
LHLABORATORY CORP OF AMERICA HOLDINGSKirchgraber Paul RCEO, Covance Drug DevelopmentFeb 14, 2022Option Exercise$272.6810829,4499,856Feb 15, 2022, 04:42 PM
LHLABORATORY CORP OF AMERICA HOLDINGSKirchgraber Paul RCEO, Covance Drug DevelopmentFeb 04, 2022Option Exercise$277.4816545,7849,647Feb 08, 2022, 11:13 AM
LHLABORATORY CORP OF AMERICA HOLDINGSKirchgraber Paul RCEO, Covance Drug DevelopmentFeb 02, 2022Option Exercise$273.1814439,3389,252Feb 04, 2022, 09:44 AM
LHLABORATORY CORP OF AMERICA HOLDINGSKirchgraber Paul RCEO, Covance Drug DevelopmentNov 01, 2021Option Exercise$288.78898259,3248,953Nov 03, 2021, 11:47 AM
LHLABORATORY CORP OF AMERICA HOLDINGSKirchgraber Paul RCEO, Covance Drug DevelopmentApr 03, 2021Option Exercise$252.67452114,20710,344Apr 06, 2021, 12:18 PM
LHLABORATORY CORP OF AMERICA HOLDINGSKirchgraber Paul RCEO, Covance Drug DevelopmentMar 27, 2021Option Exercise$251.58790198,7489,786Mar 30, 2021, 06:42 PM
LHLABORATORY CORP OF AMERICA HOLDINGSKirchgraber Paul RCEO, Covance Drug DevelopmentFeb 12, 2021Option Exercise$238.2618042,8878,472Feb 17, 2021, 04:25 PM
LHLABORATORY CORP OF AMERICA HOLDINGSKirchgraber Paul RCEO, Covance Drug DevelopmentFeb 04, 2021Option Exercise$223.7818741,8478,071Feb 08, 2021, 03:39 PM
LHLABORATORY CORP OF AMERICA HOLDINGSKirchgraber Paul RCEO, Covance Drug DevelopmentNov 04, 2020Sale$214.141,500321,2047,698Nov 06, 2020, 09:06 AM
LHLABORATORY CORP OF AMERICA HOLDINGSKirchgraber Paul RCEO, Covance Drug DevelopmentNov 02, 2020Option Exercise$207.23895185,4719,198Nov 04, 2020, 05:40 PM
LHLABORATORY CORP OF AMERICA HOLDINGSKirchgraber Paul RCEO, Covance Drug DevelopmentApr 03, 2020Option Exercise$113.3137242,1518,087Apr 07, 2020, 04:21 PM
LHLABORATORY CORP OF AMERICA HOLDINGSKirchgraber Paul RCEO, Covance Drug DevelopmentMar 30, 2020Option Exercise$131.951,014133,7977,449Apr 01, 2020, 02:29 PM
LHLABORATORY CORP OF AMERICA HOLDINGSKirchgraber Paul RCEO, Covance Drug DevelopmentFeb 12, 2020Option Exercise$187.5115929,8145,061Feb 14, 2020, 03:48 PM
LHLABORATORY CORP OF AMERICA HOLDINGSKirchgraber Paul RCEO, Covance Drug DevelopmentFeb 07, 2020Option Exercise$182.3310318,7804,641Feb 11, 2020, 01:43 PM